Australian Clinical Labs Overview
- Status
-
Public
- Employees
-
4,900
- Stock Symbol
-
ACL
- Investments
-
4
- Share Price
-
$2.26
- (As of Friday Closing)
Australian Clinical Labs General Information
Description
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Contact Information
Website
www.clinicallabs.com.auCorporate Office
- 1868-1892 Dandenong Road
- Clayton, Victoria 3168
- Australia
Corporate Office
- 1868-1892 Dandenong Road
- Clayton, Victoria 3168
- Australia
Australian Clinical Labs Timeline
Australian Clinical Labs Stock Performance
As of 29-Nov-2024, Australian Clinical Labs’s stock price is $2.26. Its current market cap is $453M with 201M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.26 | $2.27 | $1.42 - $2.64 | $453M | 201M | 1.19M | $0.08 |
Australian Clinical Labs Financials Summary
As of 30-Jun-2024, Australian Clinical Labs has a trailing 12-month revenue of $452M.
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 542,863 | 542,863 | 655,926 | 799,719 |
| Revenue | 452,005 | 452,005 | 465,286 | 716,909 |
| EBITDA | 118,834 | 118,834 | 124,202 | 270,082 |
| Net Income | 15,685 | 15,685 | 24,135 | 129,167 |
| Total Assets | 396,401 | 396,401 | 383,201 | 432,036 |
| Total Debt | 206,468 | 206,468 | 209,382 | 180,492 |
Australian Clinical Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Australian Clinical Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Australian Clinical Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Australian Clinical Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Australian Clinical Labs Investments & Acquisitions (4)
Australian Clinical Labs’s most recent deal was a Merger/Acquisition with Medlab Pathology for . The deal was made on 20-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medlab Pathology | 20-Dec-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Southern Sun Practices | 18-May-2021 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Perth Pathology | 18-Nov-2016 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| St John of God Pathology | 30-Sep-2016 | Buyout/LBO | Laboratory Services (Healthcare) |
Australian Clinical Labs Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Perth Pathology | Laboratory Services (Healthcare) | Nedlands, Australia | 2006 |
| Southern Sun Practices | Clinics/Outpatient Services | Ballina, Australia |
Australian Clinical Labs ESG
Risk Overview
Risk Rating
Updated February, 21, 2024
19.81 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,035
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Services
Subindustry
of 102
Rank
Percentile
Australian Clinical Labs FAQs
-
Where is Australian Clinical Labs headquartered?
Australian Clinical Labs is headquartered in Clayton, Australia.
-
What is the size of Australian Clinical Labs?
Australian Clinical Labs has 4,900 total employees.
-
What industry is Australian Clinical Labs in?
Australian Clinical Labs’s primary industry is Laboratory Services (Healthcare).
-
Is Australian Clinical Labs a private or public company?
Australian Clinical Labs is a Public company.
-
What is Australian Clinical Labs’s stock symbol?
The ticker symbol for Australian Clinical Labs is ACL.
-
What is the current stock price of Australian Clinical Labs?
As of 29-Nov-2024 the stock price of Australian Clinical Labs is $2.26.
-
What is the current market cap of Australian Clinical Labs?
The current market capitalization of Australian Clinical Labs is $453M.
-
What is Australian Clinical Labs’s current revenue?
The trailing twelve month revenue for Australian Clinical Labs is $452M.
-
What is Australian Clinical Labs’s annual earnings per share (EPS)?
Australian Clinical Labs’s EPS for 12 months was $0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
